Crohn's Disease and Colitis Trial, Recruiting NCT07162701 Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT07162701
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any sex are welcome to participate.
  • You must be between 18 and 64 years old.
  • You must have a confirmed diagnosis of Crohn's disease or ulcerative colitis (diagnosed for more than 3 months), based on recognised European guidelines.
  • Your condition must be moderately to severely active, and your doctor must have already decided you need a biologic medication or a JAK inhibitor treatment to help bring your disease under control.

Who may not be able to join:

  • People whose inflammatory bowel disease (IBD) cannot be clearly classified as either Crohn's disease or ulcerative colitis.
  • People who have had part of their bowel surgically removed due to IBD, unless it was only the junction between the small and large intestine (called an ileocecal resection).
  • People who have short bowel syndrome (a condition where the bowel cannot absorb enough nutrients).
  • People who need medication because their IBD has come back after surgery.
  • People who currently have active disease around the anal area.
  • People who need medication because of a narrowing or blockage in the bowel.
  • People who have previously taken part in a clinical trial involving medication for IBD.
  • People who do intense exercise (such as running or heavy gym work) more than 3 days per week (confirm with trial site).
  • People who regularly drink more than one standard alcoholic drink per day.
  • People with diabetes that is not well managed or controlled.
  • People who regularly take water tablets (diuretics).
  • People with serious kidney disease who are on dialysis.
  • People who have significant fluid retention causing swelling in the legs or fluid build-up in the abdomen.
  • People who have a cardiac pacemaker fitted.
  • Women who are pregnant or currently breastfeeding.
  • People who are unable to give their written consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0034 932919000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Registry
ClinicalTrials.gov
Start date
15 July 2025
Est. completion
15 July 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Phase angle change; Body Composition change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov